All Press

Explore the latest news, features, and media coverage highlighting Kovina’s breakthrough antiviral therapies and our mission to transform HPV cancer care.

Kovina Therapeutics Receives NIH Grant to Develop Human Papillomavirus E6 Inhibitors to Treat Oropharyngeal Cancers

Kovina Therapeutics Inc. announced receipt of a Small Business Innovation Research (SBIR) one-year Phase I award from the National Institute of Dental and Craniofacial Research

Learn more



Kovina Therapeutics Receives Grant from NIH to Advance Human Papillomavirus Premalignant Infection Treatments



Kovina Therapeutics Receives National Cancer Institute Grant to Advance Human Papillomavirus Cancer Treatment



IU-Affiliated Biotechnology Startup will use Seed Funding Toward Mission of Developing New Treatments for HPV-Related Cancer



Biotechnology Startup Receives Funding to Advance HPV Cancer Treatment

